Single-Cell Multiomics Using PTA Amplification for Accurate Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for nucleic acid amplification and sequencing from small samples, especially single cells, lack scalability, accuracy, and efficiency, particularly in simultaneous analysis of RNA, DNA, and proteins.

Innovation Solution

A method involving isolating a single cell to amplify RNA by RT-PCR, generating a cDNA library, and using terminator nucleotides to terminate genomic DNA replication, followed by sequencing both libraries, with optional dUTP and uracil-tolerant polymerases to enhance purity and accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional nucleic acid amplification methods are used for single cell analysis, then sequencing can be performed, but accuracy and scalability are insufficient

Engineering Contradiction:
Improvesequencing accuracyVSAvoidscalability
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent segments the amplification process into distinct phases: initial amplification using polymerase, termination using terminator nucleotides, and selective removal using uracil-tolerant polymerase. This segmentation allows each step to be optimized independently, achieving both high accuracy through controlled amplification and scalability through automated termination and purification steps.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an intermediary mechanism using uracil-tolerant polymerase as a mediator between the amplification step and the sequencing step. This intermediary enzyme selectively removes terminator nucleotides and purifies the amplified DNA, enabling accurate sequencing while maintaining scalability through a standardized purification process.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If RNA is amplified from single cells, then transcriptome information is obtained, but genomic DNA contamination affects purity

Engineering Contradiction:
ImprovecDNA yieldVSAvoidcDNA purity
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent extracts and removes genomic DNA contamination from the cDNA library through selective purification steps. By using uracil-tolerant polymerase that specifically recognizes and removes terminator nucleotides, the method extracts unwanted genomic DNA sequences while preserving the desired cDNA, thereby improving cDNA purity without compromising yield.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical parameter of the nucleotide mixture by incorporating terminator nucleotides with specific properties (e.g., uracil bases) that can be selectively recognized and removed. This parameter change enables differential treatment of cDNA and genomic DNA during purification, achieving high purity while maintaining adequate yield.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If terminator nucleotides are used to stop replication, then sequencing can be performed, but incomplete termination reduces accuracy

Engineering Contradiction:
Improvesequencing efficiencyVSAvoidsequence accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent implements a feedback mechanism where uracil-tolerant polymerase continuously monitors and removes remaining terminator nucleotides from the amplified DNA. This feedback loop ensures complete termination of replication and thorough removal of terminators, achieving both high sequencing efficiency and accurate sequence data without contamination from incomplete termination.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method achieves highly accurate and scalable nucleic acid amplification and sequencing, improving sequence representation, uniformity, and accuracy, enabling comprehensive multiomic analysis of single cells, including proteins, DNA, and RNA.

Implementation Method 1

contacting the genomic DNA with at least one amplification primer, at least one nucleic acid polymerase, and a mixture of nucleotides, wherein the mixture of nucleotides comprises at least one terminator nucleotide which terminates nucleic acid replication by the polymerase

Methodology Applied
Scientific EffectNucleic acid replication:

Implementation Method 2

amplifying the RNA by RT-PCR to generate a cDNA library

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 3

contacting the cDNA library with an enzyme configured to digest or remove polynucleotides from the genomic DNA library

Methodology Applied
Scientific EffectEnzymatic digestion: Enzyme

Data Source

PatentUS20250297243A1Single cell multiomics
Publication Date: 2025.09.25 BIOSKRYB GENOMICS INC
  • US20250297243A1 patent drawing
  • US20250297243A1 patent drawing
  • US20250297243A1 patent drawing

AI summary

Provided herein are compositions and methods for accurate and scalable single cell multiomics methods, and their applications for mutational analysis in research. diagnostics, and treatment. Further provided herein are multiomics methods for parallel analysis of DNA, RNA, and/or proteins from single cells using Primary Template-Directed Amplification (PTA) nucleic acid amplification.